K. Überla

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Secondary Prevention of Myocardial Infarction: a Comparison of Acetylsalicylic Acid, Placebo and Phenprocoumon

K Breddin, D Loew, Klaus Lechner et al. · Pathophysiology of Haemostasis and Thrombosis · 1980 · 108 citations

Total Mortality, Cardiovascular Pharmacology, Pharmacotherapy +20

Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo

K Breddin, D Loew, Klaus Lechner et al. · Thrombosis and Haemostasis · 1979 · 83 citations

Thrombosis, Myocardial Infarction Comparison, Acetylsalicylic Acid +11

Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued

H. Przuntek, D. Welzel, E. Blümner et al. · European Journal of Clinical Pharmacology · 1992 · 67 citations

L-dopa-treated Parkinsonian Patients, Psychotropic Medication, Pharmacology +6

[STUDIES FOR THE EVALUATION OF COLLOIDAL VOLUME SUBSTITUTION].

Ahnefeld Fw, M. Halmágyi, K. Überla · PubMed · 1965 · 35 citations

Colloidal Material, Engineering, Colloidal Property +4